Life Science Analytics Software Market by Product (Descriptive Analytics, Prescriptive Analytics, and Predictive Analytics), Application (Research & Development, Sales & Marketing Support, Regulatory Compliance, Supply Chain Analytics, and Pharmacovigilance), Delivery Model (On-premise and Cloud), End-user (Pharmaceutical & Biotechnology Companies, Medical Device Companies, Research Centers, and Third-party Administrators), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028

Global Life Science Analytics Software Market Analysis

The global life science analytics software market is anticipated to garner $13,375.8 million in the 2021–2028 period, increasing from $5,331.9 million in 2020 at a noteworthy CAGR of 12.4%.

Market Synopsis

Booming adoption of artificial intelligence (AI) in healthcare for enhancing the R&D in analytics software is one of the key drivers for the growth of the life science analytics software market. 

However, high costs associated with life science analytical software may hamper the growth of global market, during the analysis period.

According to the regional analysis of the life science analytics software market, the Asia-Pacific market is expected to surge at a CAGR of 13.4% by generating a revenue of $2,100 million, throughout the analysis period.

Life Science Analytics Software Overview

Life science analytics software helps life sciences establishments transform data into life-changing insights. This software is built with innovative technologies to help patient get better with safe therapies. Moreover, this software play key role in resolving the challenges of digital health along with improving the way of discovering, developing, manufacturing, and commercializing effective therapies. Life science professionals, scientists, and clinical researchers require data analysis in order to drive research & innovation and facilitate collaboration. The key advantages of life science analytics software are manifested in widespread areas including strategizing the intent of the patient to real world results, early detection of prescription & treatment patterns, and most importantly achieving the operational excellence to drive through the intellectual journey of patient centricity. 

Impact Analysis of COVID-19 on the Global Life Science Analytics Software Market

The life science analytics software has played a significant role, during the COVID-19 pandemic. To cope with the global pandemic, health systems, governments, retail pharmacies, payers, and nonprofits (NPOs) have been working collaboratively in order to provide widespread administration and distribution. Also, share leaders partnered to escalate research and develop the fastest novel technologies, to fight against COVID-19 crisis. For example, in May 2020, Saama Technologies Inc., significant AI-clinical analytics platform firm, and iNDX.Ai, a leading innovative software products company, announced the official launch of the ‘COVID-19 Command Center’. This center is a combination of iNDX.Ai’s iCore software and Saama’s Life Science Analytics Cloud (LSAC) which mainly helps to accelerate the ability of life sciences firms to expedite internal research & development programs for treatment of COVID-19.

Booming Adoption of AI in Healthcare for reshaping the R&D and Commercial Sector to Upsurge the Global Market Growth

Artificial intelligence (AI) is significantly prevalent in society business, and particularly in the healthcare industry. AI is rapidly becoming a key technology for the life sciences field mainly because it provides superior data, better and more efficient drug development procedures, and reduces overall healthcare costs. Also, integration of AI in healthcare analytics software has the potential to transform multiple aspects of patient care, along with administrative processes within payer, provider, and pharmaceutical enterprises.  Therefore, increasing awareness about the AI technology in the healthcare sector and hence its eye-catching adoption in the recent years, is one of the major factors, driving the life science analytics market. For instance, Pistoia Alliance, a global, not-for-profit alliance of life science companies, publishers, academic groups, and vendors, has announced the results of a survey regarding the AI and blockchain technology implementation in the life sciences market. The survey showcases that almost 62% of life science professionals say AI may lead to rapid research & development innovations. 

To know more about global life science analytics software market drivers, get in touch with our analysts here.

A Higher Initial Investment may Obstruct the Growth of the Global Life Science Analytics Software Market 

High implementation cost of life science analytics software is one of the major factors declining the global life science analytics software market growth. Also, lower product penetration, dearth of skilled personnel, and lack of IT infrastructure in the low-income economies; these factors may also restrain the global life science analytics software market, throughout the projected period.

Adoption of Advanced Analytical Tools for the Novel Drug Discovery may Create Enormous Opportunities for the Global Market in the Future

Life sciences sector worldwide has benefitted significantly from the advances in analytical solutions. Emerging technologies such as AI have a huge potential to improve and accelerate drug discovery. Also, AI powered life science analytics software aid in new drug discovery & development, drug repurposing, enhancing pharmaceutical productivity, and others.  Also, AI technology minimizes the human workload, eliminates human error and achieves targets in the short time-period. Hence, leading players in the market are coming up with effective strategic collaborations to acquire prominent position in the market, which can also positively affect the global market. For instance, in January 2020, Exscientia, a pharmatech company that uses an end-to-end AI platform to develop new drugs, and Sumitomo Dainippon Pharma, leading Japanese pharmaceutical company, used AI software to develop a drug for obsessive-compulsive disorder (OCD). This drug took only one year for the development processes to reach the trial stage. Above-stated key factors and company developments are anticipated to create massive opportunities, in the coming years.

To know more about global life science analytics software market opportunities, get in touch with our analysts here.

Global Life Science Analytics Software Market, by Product

Based on product, the market has been divided into descriptive analytics, prescriptive analytics, and predictive analytics sub-segments of which the descriptive analytics sub-segment is anticipated to have the largest market share, throughout the forecast period.

Source: Research Dive Analysis

The descriptive analytics sub-segment is expected to have the maximum share in the global market and register a revenue of $5,354.7 million by 2028. Descriptive analytics play crucial role in collecting, organizing, and presenting crucial healthcare data in proper manner. Also, the hospitals and healthcare establishments that adopted descriptive analytics Can reap the benefits of utilizing more advanced level of predictive and prescriptive analytics to enhance patients’ outcome and boost revenue generation.

Global Life Science Analytics Software Market, by Application

Based on application, the market has been categorized into research & development, sales & marketing support, regulatory compliance, supply chain analytics, and pharmacovigilance. Out of these, the sales & marketing support sub-segment is projected to garner the maximum revenue in the global market, in the upcoming years.

Source: Research Dive Analysis

The sales & marketing support sub-segment of the global life science analytics software market is expected to grow at the most notable CAGR and surpass $4,408.9 million by 2028, with a rise from $1,784.0 million in 2020. The growth of the sub-segment might be driven by the significantly increasing adoption of advanced analytics tools by life science companies in order to align their sales & marketing domain. Also, massively growing significance of post-marketing surveillance might accelerate the utilization of analytics software for sales & marketing sub-segment.

Global Life Science Analytics Software Market, by Delivery Model

Based on delivery model, the market has been categorized into on-premise and cloud. Out of these, the cloud subsegment is predicted to grow exponentially in the global life science analytics software industry, during the forecast period.

Source: Research Dive Analysis

The cloud sub-segment of the global life science analytics software market is expected to have the fastest growth and reach up to $6,708.0 million by 2028, with an increase from $2,615.3 million in 2020. The increasing demand for cloud-based life science analytics software is majorly driven by its cost-effectiveness, availability for both small and large healthcare enterprises, and increasing concern to secure healthcare records among the businesses. In addition to this, cloud based analytical tools such as Lore IO and Cloud-specific SAS offerings are the best option for healthcare organizations with a strict financial budget. Hence, the cloud-based analytical software is anticipated to have the fastest growth, during the analysis period.

Global Life Science Analytics Software Market, by End-user:

Based on end-user, the segment has been categorized into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators. Out of these, pharmaceutical & biotechnology companies sub-segment is anticipated to have a lucrative growth and it is anticipated to generate a notable revenue, throughout the forecast period.

Source: Research Dive Analysis

The pharmaceutical & biotechnology companies sub-segment of the global life science analytics software market is projected to have the dominating share and it is anticipated to cross $6,457.5 million by 2028, with an increase from $2,606.0 million in 2020. Significantly growing adoption of advanced analytical tools for enhancing clinical trial efficiency, increasing drug utilization, and resource management is creating positive impact on the sub-segment’s growth. Also, key role of analytical tools such as GDA 1.1 and DNAuser 1.0 in genome analysis and sequencing may also increase the demand for life science analytics software, in the coming years.

Global Life Science Analytics Software Market, Regional Insights:

The life science analytics software market was investigated across North America, Europe, Asia-Pacific, and LAMEA.

Source: Research Dive Analysis

The Market for Life Science Analytics Software in Asia-Pacific to be the Most Lucrative

Asia-Pacific life science analytics software market accounted $783.8 million in 2020 and is expected to register a revenue of $2,100 million by 2028.

Asia-Pacific region market is predicted to experience massive demand for eye-catching expansion of pharmaceutical & biotechnology firms particularly across India, Australia, China, and Singapore. Supportive government policies, growing prevalence of chronic diseases, and increasing spending on healthcare infrastructure are some of the factors responsible for the healthcare expansion. Also, dramatically growing prevalence of chronic diseases and rising adoption of advanced technologies such as AI and Machine learning (ML) might positively affect the APAC life science analytics market.

The North America Life Science Analytics Software Market to be the Most Dominant

North America life science analytics software market accounted $2,692.6 million in 2020 and is expected to register a revenue of $6,634.4 million by 2028. North America region market dominated the life science analytics software market and accounted for the highest revenue share in 2020, significantly due to factors such as increasing geriatric population, developed and evolving healthcare infrastructure, growing prevalence of non-communicable diseases, and widespread adoption of advanced analytical tools. Also, major technological advancements in healthcare establishments across the U.S., Canada and Mexico may fuel the North America life science analytics software market, during the projected period.

Competitive Scenario in the Global Life Science Analytics Software Market

Product launches and mergers & acquisitions are common strategies followed by major market players.

Source: Research Dive Analysis

Some of the leading life science analytics software market players are SAS Institute Inc., IQVIA HOLDINGS INC., INTERNATIONAL BUSINESS MACHINES CORPORATION, Oracle Corporation, Microsoft, Accenture, Veeva Systems Inc., American Chemical Society (ACS), ArisGlobal, and TIBCO Software Inc.

Porter’s Five Forces Analysis for the Global Life Science Analytics Software Market:

• Bargaining Power of Suppliers: The suppliers operating in the global life science analytics software are high in number and are much larger and more globalized. So, there will be less threat from the supplier.
  Thus, the bargaining power of the supplier is moderate.    
• Bargaining Power of Buyer: Buyers will have less bargaining power, significantly because of less players operating in the global life science analytics software industry.
  Thus, the bargaining power of the buyer is moderate.
• Threat of New Entrants: The companies entering into the global life science analytics software market are adopting technological innovations such as developing integrated software to attract customers. Also, these companies are implementing various effective strategies and there is government support in some countries.
  Thus, threat of the new entrants is high.
• Threat of Substitutes: There is no alternative product available. 
  Thus, the threat of substitutes is low.
• Competitive Rivalry in the Market: The competitive rivalry among the industry leaders is rather intense, especially between the global players including SAS Institute Inc., IQVIA HOLDINGS INC., and Oracle Corporation. These companies are launching their value-added services in the international market and strengthening the footprint worldwide.
  Therefore, the competitive rivalry in the market is high.